President Trump’s agreement with major pharmaceutical companies to reduce drug prices deserves more than a quick partisan reaction. It sits at the crossroads of health-care economics, executive power, and moral responsibility, and it raises a question Americans should keep asking long after the headlines fade: will this actually help patients, or is it merely another…